Author archive for Admin Isofol

  • aside

    Isofol Strengthens Executive Management Team with the Appointment of Roger Tell, MD, PhD, as Chief Scientific Officer and Senior Vice President of Clinical Development

    GOTHENBURG, Sweden, November 19, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the recruitment of…

    by
  • aside

    Isofol Announces the Appointment of Robert Marchesani as an Advisor to its Board of Directors

    GOTHENBURG, Sweden, November 16, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the appointment of…

    by
  • aside

    Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer

    GOTHENBURG, Sweden, November 15, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL) today announced initiation of the…

    by
  • aside

    Isofol presents a poster at ESMO 2018 Congress in Germany

    Isofol is attending the ESMO 2018 Congress in Germany, which is taking place between October 19-23. During Sunday the poster, “ISO-CC-005;…

    by
  • aside

    New Chairman and extended board at Isofol Medical AB (publ)

    Isofol Medical AB (publ), developing arfolitixorin as treatment for advanced colorectal cancer is calling an Extraordinary General Meeting on Wednesday…

    by
  • aside

    Patent approved in the United States for Isofol’s drug candidate arfolitixorin

    The patent now approved in the United States expires in 2037 and covers both the Active Pharmaceutical Ingredient (arfolitixorin hemisulfate),…

    by
  • aside

    DNB initiates monitoring of Isofol

    The Norwegian Bank (DNB) has initiate the monitoring of Isofol Medical AB.     For more information, please contact: Anders…

    by
  • aside

    Redeye and Isofol are inviting to the live broadcast of pre-ASCO on May 28th

    In connection to this year’s major cancer congress ASCO (American Society of Clinical Oncology) in Chicago in June, Redeye brings…

    by
  • aside

    Isofol announces that an abstract with new research results has been published for this year’s ASCO congress in Chicago

    Isofol Medical AB (publ) announces that a scientific abstract has been published for this year’s annual Congress of the American…

    by
  • aside

    Isofol reports FDAs feedback from the ongoing special protocol assessment (SPA) process

    In March 2018, Isofol Medical AB (publ) submitted a Special Protocol Assessment (SPA) to the United States Food and Drug…

    by